Horizon Therapeutics USA, INC. (Formerly Horizon Pharma USA, INC.)
Biopharmaceutical Development
Based in IL
🤖
AI Overview
With $1.6M in lobbying spend across 24 quarterly filings, Horizon Therapeutics USA, INC. (Formerly Horizon Pharma USA, INC.) is a significant lobbying presence. Their lobbying covers 3 issue areas. Active from 2018 to 2023.
$1.6M
Total Spend
6
Years Active
1
Firms Hired
6
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $290K |
| 2019 | $280K |
| 2020 | $240K |
| 2021 | $310K |
| 2022 | $240K |
| 2023 | $240K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Taxation, Health Issues
- •Medicare reimbursement issue; 340B reform.
- •Tax reform.
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.